Clinical Trial Update: EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI Treatment

View source ↗

Summary

This clinical trial update explores detecting EGFR mutations in tissue and plasma from advanced non-small cell lung cancer patients to inform EGFR-TKI treatment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EGFR-TKI (EGFR tyrosine kinase inhibitor)

Snippet

Sponsor: GenoSaber | Conditions: Non-small Cell Lung Cancer | Status: UNKNOWN